Double-blind randomized efficacy field trial of alum precipitated autoclaved Leishmania major vaccine mixed with BCG against canine visceral leishmaniasis in Meshkin-Shahr district, I.R. Iran

Vaccine

Volumn 22, Issue 29-30, 2004, Pages 4097-4100

  Mohebali, Mehdi ^a   Khamesipour, Ali ^b   Mobedi, Iraj ^a   Zarei, Zabih ^a   Hashemi Fesharki, Reza ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c RAZI VACCINE AND SERUM RESEARCH INSTITUTE   (Iran)

Author keywords

Alum precipitated autoclaved L. major vaccine; Canine visceral leishmaniasis; Leishmania vaccine

Indexed keywords

ALUMINUM POTASSIUM SULFATE; BCG VACCINE; LEISHMANIA MAJOR VACCINE; PROTOZOON ANTIBODY; SODIUM CHLORIDE; UNCLASSIFIED DRUG; VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOCLAVE; CALCULATION; CONTROLLED STUDY; DOG DISEASE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FEMALE; FOLLOW UP; HEALTH STATUS; INCIDENCE; INFECTION PREVENTION; IRAN; LEISHMANIA MAJOR; MALE; NONHUMAN; PRECIPITATION; PRIORITY JOURNAL; RANDOMIZATION; SEROCONVERSION; SINGLE DRUG DOSE; VACCINATION; VISCERAL LEISHMANIASIS;

ADJUVANTS, IMMUNOLOGIC; ALUMINUM HYDROXIDE; ANIMALS; ANTIBODIES, PROTOZOAN; BCG VACCINE; DOG DISEASES; DOGS; DOUBLE-BLIND METHOD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; INJECTIONS, INTRADERMAL; IRAN; LEISHMANIASIS, VISCERAL; MALE; PROTOZOAN VACCINES; VACCINATION;

EID: 4444307813     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.03.058     Document Type: Article

References (22)

1. Edrissian Gh.H., Nadim A., Alborzi A.V., Ardehali S. Visceral leishmaniasis: the Iranian experience. Arch. Iran. Med. 1(1):1998;22-26
2. Mohebali M., Hamzavi Y., Edissian Gh.H., Frouzani A.R. Seroepidemiological studies of visceral leishmaniasis in Bushehr province South I.R. of Iran. East. Mediterr. Health J. 7(6):2001;912-917
3. Mohebali M., Fallah E., Hamzavi Y., Zarei Z. Study on canine visceral leishmaniasis in some parts of Islamic Republic of Iran and its health importance. J. Vet. Med. Tehran University. 56(3):2001;29-32
4. Berrahal F., Mary C., Roze M., Berenger A., Escoffier K., Lamouroux D., Dunan S. Canine leishmaniasis: identification of asymptomatic carriers by polymerase chain reaction and immunoblotting. Am. J. Trop. Med. Hyg. 55:1996;273-277
5. Tesh R.B. Control of zoonotic visceral leishmaniasis, is it time to change strategies? Am. J. Trop. Med. Hyg. 52(3):1995;287-292
6. ®) in dogs with leishmaniasis. A randomized clinical trial. Vet. Q. 19:1997;10-13
7. Mohebali M., Fallah E., Jamshidi Sh., Hajjaran H. Vaccine trial against canine visceral leishmaniasis in the Islamic Republic of Iran. East. Mediterr. Health J. 4(2):1998;234-238
8. Mohebali M., Javadian E., Hashemi-Fesharki R., Mohammadzadeh M., Nadim A. Trial of non-living crude vaccine against zoonotic cutaneous leishmaniasis. Med. J. Islamic Republic Iran. 8(4):1995;211-215
9. Dowlati Y., Bahar K., Ehsasi S., Shidani B. Stepwise safety trial of killed Leishmania vaccine in Iran. Clin. Dermatol. 14(5):1996;496-502
10. Sharfi I., Fekri A.R., Aflatonian M.R., Khamesipour A., Nadim A., Mousavi M.R.V., et al. Double-blind randomized controlled vaccine trial of a single dose of killed Laishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran. Lancet. 351(9115):1998;1540-1543
11. Momeni A.R., Jalayer T., Emamjomeh M., Kamesipour A., Zicker F., Labaf Ghasemi R., et al. A randomized, double blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran. Vaccine. 17(5):1999;466-472
12. Mohebali M., Fallah E., Mobedi I., Hajjaran H. Field trial of autoclaved Leishmania vaccines for control of canine visceral leishmaniasis in Meshkin-Shahr, Iran. Arch. Razi Inst. 50:1999;87-92
13. Khalil E.A.G., El Hassan A.M., Zijlstra E.E., Mukhtat M.M., Ghalib H.W., Musa B., et al. Autoclaved L. major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan. Lancet. 356:2000;1565-1569
14. Kenney R.T., Sacks D., Sypek J.P., Vilela L., Gam A.A., Evans D., et al. Protective immunity using recombinant human IL-12 and alum as adjuvants in a primate model of cutaneous leishmaniasis. J. Immunol. 163:1999;4481-4488
15. Mistral A., Dube A., Srivastava B., Sharma P., Strivastava J.K., Kativar J.C., et al. Successful vaccination against Leishmania donovani infection in Indian langur using alum-precipitated autoclaved Leishmania major with BCG. Vaccine. 19:2001;3485-3492
16. Alimohammadian M.H., Hakimi H., Nikseresht M.A. The preparation and evaluation of reference leishmanin from Leishmania major for use in man for diagnostic and experimental purposes. Med. J. Islamic Republic Iran. 7:1993;23-28
17. Harith A.E., Slappendel R.J., Reiter I., Van Knappen F., De Korte P., Huigen E. Application of direct agglutination test for detection of specific anti-Leishmania antibodies in the canine reservoir. J. Clin. Microbiol. 27:1989;2252-2267
18. Hommel M., Peters W., Ranque J., Quilici M., Lanotte G. The micro-ELISA technique in the serodiagnosis of visceral leishmaniasis. Ann. Trop. Med. Parasitol. 72:1978;213-218
19. Gradoni L. An update on antileishmanial vaccine candidates and prospects for canine Leishmania vaccine. Vet. Parasitol. 100:2001;87-103
20. Dunan S., Frommel D., Monjour L., Ogunkolade B.W., Cruz A., Quilici M. Vaccination trial against canine visceral leishmaniasis. Parasitol. Immunol. 11:1989;397-402
21. Genaro O., Toledo V.P.C.Pd., Costa C.Ad. Vaccine for prophylaxis and immunotherapy. Clin. Dermatol. 14:1996;503-512
22. Panaro M.A. Nitric oxide production by macrophages of dogs vaccinated with killed Leishmania infantum promastigotes. Comp. Immunol. Microbiol. Infect. Dis. 24:2001;187-195